In a preclinical study, a new CAR T-cell strategy was very successful against small cell lung cancer.

Published Date: 26 Apr 2023

In a preclinical study, a novel method of CAR T-cell therapy against small cell lung cancer (SCLC) has shown great promise. Our knowledge of CAR T has been expanded by the findings.

Read Full News

Latest News

Psilocybin May Boost Abstinence in Cocaine Use Disorder

Psilocybin added to psychotherapy is associated with a greater likelihood of abstinence in cocaine use disorder than an adjunct active placebo, a study shows.

Ebola Recoveries Bring Signs Of Hope in DRC as Suspected Cases Emerge Outside Africa

Four nurses who were being treated for Ebola caused by the Bundibugyo strain of the virus have been discharged from a hospital in Bunia in the Democratic ⁠Republic of Congo...

Dual Pulmonary Hypertension Therapy Safer for Angioplasty

Dual therapy for pulmonary hypertension before balloon pulmonary angioplasty is linked to fewer thoracic complications than monotherapy in patients with chronic thromboembolic pulmonary hypertension.

Eye Inflammation Tied to Anti-Adalimumab Antibody Formation

Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.

Ralinepag Offers Once Daily Oral Option for PAH

Phase 3 data provide the foundation for a planned New Drug Application.

WHO Chief Says Fast-moving Ebola Epidemic Is Outpacing Response Efforts

The head of the World Health Organization said on Monday that the ⁠fast-moving Ebola outbreak in Democratic Republic of Congo and Uganda was outpacing response ⁠efforts,...

Todays Updates

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Snus Linked to Gingival Damage, Raising Safety Questions

Research shows that snus and newer oral nicotine pouches are associated with localized soft tissue changes, prompting greater attention to their oral health effects.

Todays Updates

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Snus Linked to Gingival Damage, Raising Safety Questions

Research shows that snus and newer oral nicotine pouches are associated with localized soft tissue changes, prompting greater attention to their oral health effects.

Latest News

Psilocybin added to psychotherapy is associated with a greater likelihood of abstinence in cocaine use disorder than an adjunct active placebo, a study shows.

Four nurses who were being treated for Ebola caused by the Bundibugyo strain of the virus have been discharged from a hospital in Bunia in the Democratic ⁠Republic of Congo...

Dual therapy for pulmonary hypertension before balloon pulmonary angioplasty is linked to fewer thoracic complications than monotherapy in patients with chronic thromboembolic pulmonary hypertension.

Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.

Phase 3 data provide the foundation for a planned New Drug Application.

The head of the World Health Organization said on Monday that the ⁠fast-moving Ebola outbreak in Democratic Republic of Congo and Uganda was outpacing response ⁠efforts,...

News All Time

Self-Screening Tool for AxSpA Aims to Lower Diagnostic Delay

The patient self-screening tool that was developed to help identify axial spondyloarthritis promises to cut time to diagnosis and is being evaluated in a large European cohort.

Single Bevacizumab Dose Sustains Trabeculectomy Success

A single injection of bevacizumab given during glaucoma surgery is associated with improved chances of surgical success even 3 years after the operation, a follow-up study of a clinical trial shows.

For Med Students, Finding the Right Mentor Can Be a Boost

Start with your advisors to find a mentor in your specialty or in another.

Treprostinil Turns Heads in Promising IPF Study

Data from the TETON-1 phase 3 trial showed even greater response over TETON-2 study.

Ketamine Tied to Rapid Relief of Depression Symptoms

A meta-analysis links intravenous ketamine with significant reductions in suicidal thoughts and depressive symptoms within hours of treatment.

Talking Bot Wins Over Patients and Docs in Ophthalmology

A voice-based generative AI assistant designed for patient education in ophthalmology is well received by patients, healthcare professionals, and practice managers, according to a qualitative study.

CDC Offers Hantavirus Guidance, Says Risk Is Extremely Low

Forty-one Americans considered at higher risk are being monitored, while public health labs scramble to validate PCR assays that can detect infection before symptoms start.

ECMO Cannulation Improves Outcomes as Lung Transplant Bridge

Clinical advantage was notable in older patients.

'Deadly Mix' Puts Patients at Risk, RCN Congress Hears

A quarter of nurses say staffing on their last shift was so far below what was needed that patients and staff faced a high risk of harm, an RCN survey shows.

Flawed Tests and Funerals Allowed Ebola to Spread Undetected, Sources Say

By the time health officials confirmed new Ebola infections in eastern Democratic Republic of Congo last week, the total number of suspected cases meant the outbreak was...

American Doctor Has Ebola, Will Be Transferred for Care

Two other physicians — including the doctor’s wife — were potentially exposed, along with their four children.

FDA Psychiatry Roundup: April 2026

A monthly snapshot of FDA activity involving therapies used in the prevention and treatment of psychiatric conditions.

Is Ketamine for Depression Moving Too Fast on Weak Data?

Ketamine has been hailed as a fast-acting, effective treatment for major depression. But new research questions whether the drug lives up to its hype.

IA Thrombolysis After Thrombectomy: More Uncertainty

The TECNO trial finds no clear reperfusion benefit from intra-arterial thrombolysis after thrombectomy in acute ischemic stroke, raising fresh doubts about the strategy.

Soccer-Study Warns Of Dangerous Heat At 2026 World Cup as Climate Risks Grow

Football's global players' union renewed concerns on Thursday about heat at the 2026 World Cup after scientists warned the likelihood of dangerous temperatures for players...

Aging in Hospital Medicine: How to Retain Older Hospitalists

The schedule and demanding nature of the job make hospitalist jobs more difficult as you age. Some systems are trying to help.

Recommended News For You

For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.

FDA Approves Treosulfan as Part of AML/MDS Conditioning Regimen

Certain Oral Bacteria May Be a Risk Factor for Head and Neck Cancer

combating racial discrimination in next-generation breast cancer screening.

Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.

Hybrid imaging test combines antibody and radioisotope for early lung cancer detection

Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy

Recommended Articles For You

Building Bridges between Heart and Cancer Care: A Comprehensive Guide to Cardio-Oncology Clinics 

Exploring Innovative Approaches to Esophageal Cancer Treatment 

Emicizumab in Infants with Severe Hemophilia A: HAVEN 7 Phase 3b Trial Insights 

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cabozantinib Improves PFS for Advanced Neuroendocrine Tumors

2.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

3.

Do I qualify for a cancer clinical trial?

4.

'It's rare and it's scary.' Dark spot on your fingernail could mean cancer

5.

When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.

1.

Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment

2.

MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps

3.

Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment

4.

Cancer Rates on the Rise: What Can We Do to Stop It?

5.

Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

5.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot